RxDoctor Payments Data

Shelby Scullen, NP

Family · Watertown, NYNPI 1194508952

Payments from drug & device makers

$1,879in general payments, 2019–2025

Across 76 payments — averaging $24.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$325
  • Axonics, Inc.$198
  • 180 Medical, Inc.$188
  • Astellas Pharma US Inc$157
  • Endo USA, Inc.$95
  • Ferring Pharmaceuticals Inc.$86
  • plus $830 from 22 others

What the payments were for

  • Food & beverage$1,68790%
  • Education$19210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,879 in reported general payments places this provider in the 80th percentile of 8,883 family providers in New York.

See all family providers in New York

Medicare billing

Part B allowed, 2024
$16,669
Medicare patients
180
Services billed
273

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron123$82,999
GemtesaVibegron55$27,578
Methenamine Hippurate23$1,933
Tamsulosin Hcl219$1,519
Oxybutynin Chloride ErOxybutynin Chloride79$728
Finasteride65$466
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst35$375
Oxybutynin Chloride38$238
Solifenacin Succinate27$189
Cefdinir14$182
Alfuzosin Hcl ErAlfuzosin Hcl11$131
Levofloxacin26$66
Ciprofloxacin Hcl29$65
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim18$54
Cephalexin11$40

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$157$82,999123 claims
Sumitomo Pharma America, Inc.Gemtesa$71$27,57855 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,883 family providers in New York.

Other family in Watertown

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →